日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2021/04/20 | 21 : 45 | GlobeNewswire Inc. | Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of Directors | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/09/28 | 02 : 22 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/09/19 | 03 : 03 | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/11 | 05 : 56 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/10 | 05 : 40 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/07 | 01 : 00 | Business Wire | Foundation Medicine Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predicto... | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/04 | 06 : 58 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/04 | 06 : 51 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/04 | 06 : 43 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/04 | 06 : 26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/04 | 06 : 26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 08 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 05 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/08/03 | 02 : 46 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/07/31 | 22 : 02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/07/31 | 21 : 59 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/07/31 | 21 : 55 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |
2018/07/31 | 21 : 47 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:FMI | Foundation Medicine, Inc. (delisted) |